UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Genomictree targets multimillion-dollar US market with non-invasive diagnostic kit
Genomictree is on the threshold of advancing to the U.S. market for non-inv...
by Park Gi-taek
|
2019-07-18 09:00
라인
‘Myongji will show what Korean Mayo Clinic looks like’
“I came here to turn this hospital into a Korean version of Mayo Clinic, pr...
by Park Gi-taek
|
2019-07-12 15:30
라인
‘Expensive immunotherapies are not cure-all’
“Immunotherapies are increasingly drawing attention, but they cannot solve ...
by Park Gi-taek
|
2019-06-24 14:46
라인
‘Indoor radon exposure raises tumor mutation in lung cancer patients’
Indoor radon exposure increases tumor gene mutation in non-smoking patients...
by Park Gi-taek
|
2019-06-04 14:19
라인
AbbVie’s chronic lymphocytic leukemia drug wins Korean license
AbbVie Korea said it obtained the Ministry of Food and Drug Safety’s approv...
by Park Gi-taek
|
2019-05-30 15:14
라인
Canon’s CT analysis software wins recognition as new medical technology
Canon Medical Systems Korea said its software “4D Orthopedic Analysis” of t...
by Park Gi-taek
|
2019-05-14 15:28
라인
‘Darzalex as another weapon against multiple myeloma’
Janssen Korea’s Darzalex (ingredient: daratumumab) is effective for heavily...
by Park Gi-taek
|
2019-04-19 15:39
라인
Brexit to take toll on Korean medical device makers
“We are seriously concerned about no-deal Brexit. In the worst scenario, it...
by Park Gi-taek
|
2019-04-16 16:18
라인
Drop did not kill newborn, says CHA Bundang hospital
A tertiary hospital in Seongnam near Seoul came under suspicion that it int...
by Park Gi-taek
|
2019-04-15 15:20
라인
Antitrust watchdog raids 3 leading stent makers
The Fair Trade Commission is probing three key players in the domestic sten...
by Park Gi-taek
|
2019-03-27 14:28
라인
Doctors outrageous over MSD Korea’s recordings of their talks
Korean doctors are enraged, criticizing MSD Korea’s alleged collection of f...
by Park Gi-taek
|
2019-03-25 16:05
라인
Researchers find biomarker to predict recurrence of chronic myeloid leukemia
Korean researchers said they have discovered a biomarker to predict a thera...
by Park Gi-taek
|
2019-02-25 16:03
라인
Direct-to-consumer genetic testing allowed for Parkinson’s, lung cancer
The government has decided to include direct-to-consumer genetic testing in...
by Park Gi-taek
|
2019-02-12 14:48
라인
Demands for MMR vaccines spike amid resurgence of measles
Amid a rise of measles patients, clinics are suffering a shortage of MMR (m...
by Park Gi-taek
|
2019-02-12 11:19
라인
Bioneer’s HIV diagnostic kit registered on Global Fund’s purchase list
Bioneer said its human immunodeficiency virus type 1 (HIV-1) diagnostic kit...
by Park Gi-taek
|
2019-02-08 16:46
라인
Korean firms ink $232 million surgical device export deals in Dubai
Korean medical device makers showcased an integrated showroom of surgical d...
by Park Gi-taek
|
2019-02-07 11:55
라인
Ipsen’s renal cancer drug Carbometyx gets insurance benefit
Ipsen Korea’s advanced renal cell carcinoma treatment Carbometyx (cabozanti...
by Park Gi-taek
|
2019-01-31 11:13
라인
Drug distributors to report Novo Nordisk to antitrust watchdog over ‘unfair trade’
The Korea Pharmaceutical Distribution Association (KPDA) is seeking to file...
by Park Gi-taek
|
2019-01-22 14:18
라인
‘Half of the subfertile see doctor 3 years after trying pregnancy’
About half of patients with subfertility seek medical help three years afte...
by Park Gi-taek
|
2019-01-21 11:44
라인
Healcerion’s wireless ultrasound Sonon sold out in Japan
Healcerion said it has completed selling the first 100 units of Sonon, a ha...
by Park Gi-taek
|
2019-01-18 11:46
-
1
2
3
4
5
6
7
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top